primary antibodies for ddr2 Search Results


94
Cell Signaling Technology Inc cell signaling technology ddr2
shRNA-mediated knockdown of <t>DDR2.</t> ( A ) DDR2 mRNA expression across cancer lines was ana-lyzed in the Dependency Map Portal ( https://depmap.org/portal ; Broad Institute, accessed on 15 February 2024). ( B ) Western blot of DDR2 expression (vs. GAPDH) upon 4 days of doxycycline treatment (0–12.5 mg/mL) on Tet-shDDR2 SHSY5Y cells. ( C ) Cell survival/proliferation time course assay (as measured by % confluency) of Tet-shDDR2 SHSY5Y cells treated with doxycycline (on day 0) at increasing concentrations as indicated ( n = 6 wells/condition). ( D ) Western blot of DDR2 and phospho-tyrosine 740-DDR2 (phY740-DDR2) from Tet-shDDR2 SHSY5Y cells pretreated for 3 days with the indicated concentrations of doxycycline and left unstimulated or induced with 25 mg/mL of rat-tail type I collagen for 16 h. Protein quantification data for Western blots can be found in .
Cell Signaling Technology Ddr2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/DDR2+Antibody/pmc11509142-57-4-4
Average 94 stars, based on 1 article reviews
cell signaling technology ddr2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Proteintech ddr2
shRNA-mediated knockdown of <t>DDR2.</t> ( A ) DDR2 mRNA expression across cancer lines was ana-lyzed in the Dependency Map Portal ( https://depmap.org/portal ; Broad Institute, accessed on 15 February 2024). ( B ) Western blot of DDR2 expression (vs. GAPDH) upon 4 days of doxycycline treatment (0–12.5 mg/mL) on Tet-shDDR2 SHSY5Y cells. ( C ) Cell survival/proliferation time course assay (as measured by % confluency) of Tet-shDDR2 SHSY5Y cells treated with doxycycline (on day 0) at increasing concentrations as indicated ( n = 6 wells/condition). ( D ) Western blot of DDR2 and phospho-tyrosine 740-DDR2 (phY740-DDR2) from Tet-shDDR2 SHSY5Y cells pretreated for 3 days with the indicated concentrations of doxycycline and left unstimulated or induced with 25 mg/mL of rat-tail type I collagen for 16 h. Protein quantification data for Western blots can be found in .
Ddr2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/DDR2+Antibody/pm41533176-120-5-6
Average 94 stars, based on 1 article reviews
ddr2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology discoidin domain receptor 2
shRNA-mediated knockdown of <t>DDR2.</t> ( A ) DDR2 mRNA expression across cancer lines was ana-lyzed in the Dependency Map Portal ( https://depmap.org/portal ; Broad Institute, accessed on 15 February 2024). ( B ) Western blot of DDR2 expression (vs. GAPDH) upon 4 days of doxycycline treatment (0–12.5 mg/mL) on Tet-shDDR2 SHSY5Y cells. ( C ) Cell survival/proliferation time course assay (as measured by % confluency) of Tet-shDDR2 SHSY5Y cells treated with doxycycline (on day 0) at increasing concentrations as indicated ( n = 6 wells/condition). ( D ) Western blot of DDR2 and phospho-tyrosine 740-DDR2 (phY740-DDR2) from Tet-shDDR2 SHSY5Y cells pretreated for 3 days with the indicated concentrations of doxycycline and left unstimulated or induced with 25 mg/mL of rat-tail type I collagen for 16 h. Protein quantification data for Western blots can be found in .
Discoidin Domain Receptor 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/ROR2+Antibody/pmc02817534-101-26-33
Average 93 stars, based on 1 article reviews
discoidin domain receptor 2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti ddr2
shRNA-mediated knockdown of <t>DDR2.</t> ( A ) DDR2 mRNA expression across cancer lines was ana-lyzed in the Dependency Map Portal ( https://depmap.org/portal ; Broad Institute, accessed on 15 February 2024). ( B ) Western blot of DDR2 expression (vs. GAPDH) upon 4 days of doxycycline treatment (0–12.5 mg/mL) on Tet-shDDR2 SHSY5Y cells. ( C ) Cell survival/proliferation time course assay (as measured by % confluency) of Tet-shDDR2 SHSY5Y cells treated with doxycycline (on day 0) at increasing concentrations as indicated ( n = 6 wells/condition). ( D ) Western blot of DDR2 and phospho-tyrosine 740-DDR2 (phY740-DDR2) from Tet-shDDR2 SHSY5Y cells pretreated for 3 days with the indicated concentrations of doxycycline and left unstimulated or induced with 25 mg/mL of rat-tail type I collagen for 16 h. Protein quantification data for Western blots can be found in .
Anti Ddr2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/DDR2+Antibody/pm15254913-114-19-28
Average 93 stars, based on 1 article reviews
anti ddr2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems goat anti human ddr2 polyclonal antibody
Figure 1. Phosphorylation of <t>DDR2</t> in 3D collagen matrix. (A) Collagen matrices containing human fibroblasts were polymerized for 1 h (labeled 0 h) and incubated with PDGF for 4 h as shown. At the end of the incubations, cells were harvested and immunoprecipitated using phosphotyrosine antibodies (PY20), after which half of the samples were subjected to immunoblotting with antibodies (4G10) to detect phosphotyrosine protein (left panel). The major tyrosine- phosphorylated protein is indicated by an asterisk on the right. Half of the samples were subjected to silver staining and major precipitated proteins were analyzed by MALDI-TOF mass spectrometry (right panel). The results of the mass spectrometry are shown on the right. (B) RT-PCR showing that DDR2 siRNA, but not mock-transfected cells, specifically inhibited DDR2 expression. (C) Collagen matrices containing control and DDR2 silenced fibroblasts were incubated with PDGF for 4 h. At the end of the incubations, lysates were prepared and subjected to immunoblotting with antibodies (4G10) directly against the phosphotyrosine protein. The arrow indicates that the phosphotyrosine protein of 135 kDa size protein completely disappeared with DDR2 siRNA.
Goat Anti Human Ddr2 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/Human+DDR2+Antibody/pm23546533-39-3-9
Average 93 stars, based on 1 article reviews
goat anti human ddr2 polyclonal antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems p ddr1 2
Figure 1. Phosphorylation of <t>DDR2</t> in 3D collagen matrix. (A) Collagen matrices containing human fibroblasts were polymerized for 1 h (labeled 0 h) and incubated with PDGF for 4 h as shown. At the end of the incubations, cells were harvested and immunoprecipitated using phosphotyrosine antibodies (PY20), after which half of the samples were subjected to immunoblotting with antibodies (4G10) to detect phosphotyrosine protein (left panel). The major tyrosine- phosphorylated protein is indicated by an asterisk on the right. Half of the samples were subjected to silver staining and major precipitated proteins were analyzed by MALDI-TOF mass spectrometry (right panel). The results of the mass spectrometry are shown on the right. (B) RT-PCR showing that DDR2 siRNA, but not mock-transfected cells, specifically inhibited DDR2 expression. (C) Collagen matrices containing control and DDR2 silenced fibroblasts were incubated with PDGF for 4 h. At the end of the incubations, lysates were prepared and subjected to immunoblotting with antibodies (4G10) directly against the phosphotyrosine protein. The arrow indicates that the phosphotyrosine protein of 135 kDa size protein completely disappeared with DDR2 siRNA.
P Ddr1 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/Human+Phospho-DDR1%2FDDR2+(DDR1+Y796%2C+DDR2+Y740)+Antibody/pmc12629827-601-36-38
Average 93 stars, based on 1 article reviews
p ddr1 2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio ddr2
Figure 1. Phosphorylation of <t>DDR2</t> in 3D collagen matrix. (A) Collagen matrices containing human fibroblasts were polymerized for 1 h (labeled 0 h) and incubated with PDGF for 4 h as shown. At the end of the incubations, cells were harvested and immunoprecipitated using phosphotyrosine antibodies (PY20), after which half of the samples were subjected to immunoblotting with antibodies (4G10) to detect phosphotyrosine protein (left panel). The major tyrosine- phosphorylated protein is indicated by an asterisk on the right. Half of the samples were subjected to silver staining and major precipitated proteins were analyzed by MALDI-TOF mass spectrometry (right panel). The results of the mass spectrometry are shown on the right. (B) RT-PCR showing that DDR2 siRNA, but not mock-transfected cells, specifically inhibited DDR2 expression. (C) Collagen matrices containing control and DDR2 silenced fibroblasts were incubated with PDGF for 4 h. At the end of the incubations, lysates were prepared and subjected to immunoblotting with antibodies (4G10) directly against the phosphotyrosine protein. The arrow indicates that the phosphotyrosine protein of 135 kDa size protein completely disappeared with DDR2 siRNA.
Ddr2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/Anti-DDR2+Antibody+Picoband/pm33603168-312-3-6
Average 90 stars, based on 1 article reviews
ddr2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Servicebio Inc anti ddr2
(A) CBF assessed by LSCI in WT, APP/PS1, and astrocyte specific <t>Ddr2</t> overexpressing APP/PS1 mice. Left: Representative pseudocolor perfusion maps. Right: Quantification of relative perfusion units (Mean ± SEM; ** p < 0.01, one-way ANOVA). (B) Correlation between CBF (from A) and cortical Ddr2 mRNA levels (qPCR) across individual mice (Pearson r = −0.6081, p < 0.01). (C) In vivo (top) and ex vivo (bottom) whole brain fluorescence imaging after intravenous injection of the DDR2 targeting probe 1A12-mCherry. (D) Validation of 1A12-mCherry brain delivery and target specificity: Ex vivo brain sections for intrinsic mCherry fluorescence (red), anti-His tag immunofluorescence staining (green), <t>and</t> <t>anti-DDR2</t> antibody HL2 staining (purple), the areas outlined by white squares are magnified in the adjacent panels. Scale bar: 30 μm for original images and 10 μm for enlarged images. (E) Schematic of the sequential probe injection protocol for vascular perfusion assessment: 1A12-mCherry followed 40 min later by Dextran-FITC (70 kDa). (F) Whole brain fluorescence imaging of vascular perfusion with Dextran-FITC (70 kDa). (G) Two photon microscopy of cortical vasculature. Representative images show mCherry signal (red) and dextran-FITC vasculature (green) in WT, APP/PS1, and APP/PS1-DDR2 mice, scale bars: 50 μm. (H) Representative two-photon microscopy images of vascular leakage after injection of dextran-FITC (4 kDa, green) and dextran-RB (70 kDa, red), scale bars: 50 μm. (I) Ventricular morphology analyzed by MRI based volumetric reconstruction. Left: Representative images of lateral ventricles from each group. Right: Quantification of lateral ventricular volume (Mean ± SEM; * p < 0.05, ** p < 0.01, one-way ANOVA). (J) CSF flow assessed by cisterna magna injection of high molecular weight dextran (70 kDa, green). Fluorescence stereo microscope images displaying the spatial distribution of the glymphatic system (green) in the brains ( top row ), and corresponding whole brain fluorescence imaging system scans of the same brains( bottom row ), scale bars: 2 mm.
Anti Ddr2, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/anti+ddr2/med_rxiv__64898__2026__03__17__26348575-262-10-12
Average 86 stars, based on 1 article reviews
anti ddr2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Regeneron inc primary polyclonal ddr2 (r2-jm) antibody
(A) CBF assessed by LSCI in WT, APP/PS1, and astrocyte specific <t>Ddr2</t> overexpressing APP/PS1 mice. Left: Representative pseudocolor perfusion maps. Right: Quantification of relative perfusion units (Mean ± SEM; ** p < 0.01, one-way ANOVA). (B) Correlation between CBF (from A) and cortical Ddr2 mRNA levels (qPCR) across individual mice (Pearson r = −0.6081, p < 0.01). (C) In vivo (top) and ex vivo (bottom) whole brain fluorescence imaging after intravenous injection of the DDR2 targeting probe 1A12-mCherry. (D) Validation of 1A12-mCherry brain delivery and target specificity: Ex vivo brain sections for intrinsic mCherry fluorescence (red), anti-His tag immunofluorescence staining (green), <t>and</t> <t>anti-DDR2</t> antibody HL2 staining (purple), the areas outlined by white squares are magnified in the adjacent panels. Scale bar: 30 μm for original images and 10 μm for enlarged images. (E) Schematic of the sequential probe injection protocol for vascular perfusion assessment: 1A12-mCherry followed 40 min later by Dextran-FITC (70 kDa). (F) Whole brain fluorescence imaging of vascular perfusion with Dextran-FITC (70 kDa). (G) Two photon microscopy of cortical vasculature. Representative images show mCherry signal (red) and dextran-FITC vasculature (green) in WT, APP/PS1, and APP/PS1-DDR2 mice, scale bars: 50 μm. (H) Representative two-photon microscopy images of vascular leakage after injection of dextran-FITC (4 kDa, green) and dextran-RB (70 kDa, red), scale bars: 50 μm. (I) Ventricular morphology analyzed by MRI based volumetric reconstruction. Left: Representative images of lateral ventricles from each group. Right: Quantification of lateral ventricular volume (Mean ± SEM; * p < 0.05, ** p < 0.01, one-way ANOVA). (J) CSF flow assessed by cisterna magna injection of high molecular weight dextran (70 kDa, green). Fluorescence stereo microscope images displaying the spatial distribution of the glymphatic system (green) in the brains ( top row ), and corresponding whole brain fluorescence imaging system scans of the same brains( bottom row ), scale bars: 2 mm.
Primary Polyclonal Ddr2 (R2 Jm) Antibody, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/ddr2+null+mutation+mouse+strain/10__1074_slash_jbc__m508226200-26-2-9
Average 90 stars, based on 1 article reviews
primary polyclonal ddr2 (r2-jm) antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology primary antibodies
(A) CBF assessed by LSCI in WT, APP/PS1, and astrocyte specific <t>Ddr2</t> overexpressing APP/PS1 mice. Left: Representative pseudocolor perfusion maps. Right: Quantification of relative perfusion units (Mean ± SEM; ** p < 0.01, one-way ANOVA). (B) Correlation between CBF (from A) and cortical Ddr2 mRNA levels (qPCR) across individual mice (Pearson r = −0.6081, p < 0.01). (C) In vivo (top) and ex vivo (bottom) whole brain fluorescence imaging after intravenous injection of the DDR2 targeting probe 1A12-mCherry. (D) Validation of 1A12-mCherry brain delivery and target specificity: Ex vivo brain sections for intrinsic mCherry fluorescence (red), anti-His tag immunofluorescence staining (green), <t>and</t> <t>anti-DDR2</t> antibody HL2 staining (purple), the areas outlined by white squares are magnified in the adjacent panels. Scale bar: 30 μm for original images and 10 μm for enlarged images. (E) Schematic of the sequential probe injection protocol for vascular perfusion assessment: 1A12-mCherry followed 40 min later by Dextran-FITC (70 kDa). (F) Whole brain fluorescence imaging of vascular perfusion with Dextran-FITC (70 kDa). (G) Two photon microscopy of cortical vasculature. Representative images show mCherry signal (red) and dextran-FITC vasculature (green) in WT, APP/PS1, and APP/PS1-DDR2 mice, scale bars: 50 μm. (H) Representative two-photon microscopy images of vascular leakage after injection of dextran-FITC (4 kDa, green) and dextran-RB (70 kDa, red), scale bars: 50 μm. (I) Ventricular morphology analyzed by MRI based volumetric reconstruction. Left: Representative images of lateral ventricles from each group. Right: Quantification of lateral ventricular volume (Mean ± SEM; * p < 0.05, ** p < 0.01, one-way ANOVA). (J) CSF flow assessed by cisterna magna injection of high molecular weight dextran (70 kDa, green). Fluorescence stereo microscope images displaying the spatial distribution of the glymphatic system (green) in the brains ( top row ), and corresponding whole brain fluorescence imaging system scans of the same brains( bottom row ), scale bars: 2 mm.
Primary Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/Vimentin/pm27010547-63-21-43
Average 96 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

99
NSJ Bioreagents mcm5 antibody
(A) CBF assessed by LSCI in WT, APP/PS1, and astrocyte specific <t>Ddr2</t> overexpressing APP/PS1 mice. Left: Representative pseudocolor perfusion maps. Right: Quantification of relative perfusion units (Mean ± SEM; ** p < 0.01, one-way ANOVA). (B) Correlation between CBF (from A) and cortical Ddr2 mRNA levels (qPCR) across individual mice (Pearson r = −0.6081, p < 0.01). (C) In vivo (top) and ex vivo (bottom) whole brain fluorescence imaging after intravenous injection of the DDR2 targeting probe 1A12-mCherry. (D) Validation of 1A12-mCherry brain delivery and target specificity: Ex vivo brain sections for intrinsic mCherry fluorescence (red), anti-His tag immunofluorescence staining (green), <t>and</t> <t>anti-DDR2</t> antibody HL2 staining (purple), the areas outlined by white squares are magnified in the adjacent panels. Scale bar: 30 μm for original images and 10 μm for enlarged images. (E) Schematic of the sequential probe injection protocol for vascular perfusion assessment: 1A12-mCherry followed 40 min later by Dextran-FITC (70 kDa). (F) Whole brain fluorescence imaging of vascular perfusion with Dextran-FITC (70 kDa). (G) Two photon microscopy of cortical vasculature. Representative images show mCherry signal (red) and dextran-FITC vasculature (green) in WT, APP/PS1, and APP/PS1-DDR2 mice, scale bars: 50 μm. (H) Representative two-photon microscopy images of vascular leakage after injection of dextran-FITC (4 kDa, green) and dextran-RB (70 kDa, red), scale bars: 50 μm. (I) Ventricular morphology analyzed by MRI based volumetric reconstruction. Left: Representative images of lateral ventricles from each group. Right: Quantification of lateral ventricular volume (Mean ± SEM; * p < 0.05, ** p < 0.01, one-way ANOVA). (J) CSF flow assessed by cisterna magna injection of high molecular weight dextran (70 kDa, green). Fluorescence stereo microscope images displaying the spatial distribution of the glymphatic system (green) in the brains ( top row ), and corresponding whole brain fluorescence imaging system scans of the same brains( bottom row ), scale bars: 2 mm.
Mcm5 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+ddr2/MCM5+Antibody/custom%40rq6284%4037737519
Average 99 stars, based on 1 article reviews
mcm5 antibody - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


shRNA-mediated knockdown of DDR2. ( A ) DDR2 mRNA expression across cancer lines was ana-lyzed in the Dependency Map Portal ( https://depmap.org/portal ; Broad Institute, accessed on 15 February 2024). ( B ) Western blot of DDR2 expression (vs. GAPDH) upon 4 days of doxycycline treatment (0–12.5 mg/mL) on Tet-shDDR2 SHSY5Y cells. ( C ) Cell survival/proliferation time course assay (as measured by % confluency) of Tet-shDDR2 SHSY5Y cells treated with doxycycline (on day 0) at increasing concentrations as indicated ( n = 6 wells/condition). ( D ) Western blot of DDR2 and phospho-tyrosine 740-DDR2 (phY740-DDR2) from Tet-shDDR2 SHSY5Y cells pretreated for 3 days with the indicated concentrations of doxycycline and left unstimulated or induced with 25 mg/mL of rat-tail type I collagen for 16 h. Protein quantification data for Western blots can be found in .

Journal: Life

Article Title: Investigation of Cell Mechanics and Migration on DDR2-Expressing Neuroblastoma Cell Line

doi: 10.3390/life14101260

Figure Lengend Snippet: shRNA-mediated knockdown of DDR2. ( A ) DDR2 mRNA expression across cancer lines was ana-lyzed in the Dependency Map Portal ( https://depmap.org/portal ; Broad Institute, accessed on 15 February 2024). ( B ) Western blot of DDR2 expression (vs. GAPDH) upon 4 days of doxycycline treatment (0–12.5 mg/mL) on Tet-shDDR2 SHSY5Y cells. ( C ) Cell survival/proliferation time course assay (as measured by % confluency) of Tet-shDDR2 SHSY5Y cells treated with doxycycline (on day 0) at increasing concentrations as indicated ( n = 6 wells/condition). ( D ) Western blot of DDR2 and phospho-tyrosine 740-DDR2 (phY740-DDR2) from Tet-shDDR2 SHSY5Y cells pretreated for 3 days with the indicated concentrations of doxycycline and left unstimulated or induced with 25 mg/mL of rat-tail type I collagen for 16 h. Protein quantification data for Western blots can be found in .

Article Snippet: Primary antibodies were: from Cell Signaling Technology DDR2 (#12133); from MilliporeSigma (Darmstadt, Germany) Anti-GAPDH antibody (MAB374); and from R & D Systems human phopho-DDR1/DDR2 (Y796/Y740) antibody (MAB25382).

Techniques: shRNA, Knockdown, Expressing, Western Blot

DDR2 downregulation decreases neuroblastoma cell stiffness. Young’s modulus measurements of ( A ) shCTRL and shDDR2 cells using atomic force microscopy. Indentation of ( B ) cell front (red arrow), ( C ) cell middle (blue arrow), and ( D ) cell back (yellow arrow). Young’s modulus of experiments were performed in three independent experiments. Unpaired t -test, * p < 0.05; *** p < 0.001 ( n = 32–33 cells). Data are presented as ± s.e.m.

Journal: Life

Article Title: Investigation of Cell Mechanics and Migration on DDR2-Expressing Neuroblastoma Cell Line

doi: 10.3390/life14101260

Figure Lengend Snippet: DDR2 downregulation decreases neuroblastoma cell stiffness. Young’s modulus measurements of ( A ) shCTRL and shDDR2 cells using atomic force microscopy. Indentation of ( B ) cell front (red arrow), ( C ) cell middle (blue arrow), and ( D ) cell back (yellow arrow). Young’s modulus of experiments were performed in three independent experiments. Unpaired t -test, * p < 0.05; *** p < 0.001 ( n = 32–33 cells). Data are presented as ± s.e.m.

Article Snippet: Primary antibodies were: from Cell Signaling Technology DDR2 (#12133); from MilliporeSigma (Darmstadt, Germany) Anti-GAPDH antibody (MAB374); and from R & D Systems human phopho-DDR1/DDR2 (Y796/Y740) antibody (MAB25382).

Techniques: Microscopy

Figure 1. Phosphorylation of DDR2 in 3D collagen matrix. (A) Collagen matrices containing human fibroblasts were polymerized for 1 h (labeled 0 h) and incubated with PDGF for 4 h as shown. At the end of the incubations, cells were harvested and immunoprecipitated using phosphotyrosine antibodies (PY20), after which half of the samples were subjected to immunoblotting with antibodies (4G10) to detect phosphotyrosine protein (left panel). The major tyrosine- phosphorylated protein is indicated by an asterisk on the right. Half of the samples were subjected to silver staining and major precipitated proteins were analyzed by MALDI-TOF mass spectrometry (right panel). The results of the mass spectrometry are shown on the right. (B) RT-PCR showing that DDR2 siRNA, but not mock-transfected cells, specifically inhibited DDR2 expression. (C) Collagen matrices containing control and DDR2 silenced fibroblasts were incubated with PDGF for 4 h. At the end of the incubations, lysates were prepared and subjected to immunoblotting with antibodies (4G10) directly against the phosphotyrosine protein. The arrow indicates that the phosphotyrosine protein of 135 kDa size protein completely disappeared with DDR2 siRNA.

Journal: International journal of molecular medicine

Article Title: Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices.

doi: 10.3892/ijmm.2013.1320

Figure Lengend Snippet: Figure 1. Phosphorylation of DDR2 in 3D collagen matrix. (A) Collagen matrices containing human fibroblasts were polymerized for 1 h (labeled 0 h) and incubated with PDGF for 4 h as shown. At the end of the incubations, cells were harvested and immunoprecipitated using phosphotyrosine antibodies (PY20), after which half of the samples were subjected to immunoblotting with antibodies (4G10) to detect phosphotyrosine protein (left panel). The major tyrosine- phosphorylated protein is indicated by an asterisk on the right. Half of the samples were subjected to silver staining and major precipitated proteins were analyzed by MALDI-TOF mass spectrometry (right panel). The results of the mass spectrometry are shown on the right. (B) RT-PCR showing that DDR2 siRNA, but not mock-transfected cells, specifically inhibited DDR2 expression. (C) Collagen matrices containing control and DDR2 silenced fibroblasts were incubated with PDGF for 4 h. At the end of the incubations, lysates were prepared and subjected to immunoblotting with antibodies (4G10) directly against the phosphotyrosine protein. The arrow indicates that the phosphotyrosine protein of 135 kDa size protein completely disappeared with DDR2 siRNA.

Article Snippet: Primary antibodies were: goat anti-human DDR2 (polyclonal) antibody from R&D Systems (Minneapolis, MN, USA) and Type I rat tail collagen (10.6 mg/ml) purchased from BD Biosciences (Bedford, MA, USA).

Techniques: Phospho-proteomics, Labeling, Incubation, Immunoprecipitation, Western Blot, Silver Staining, Mass Spectrometry, Reverse Transcription Polymerase Chain Reaction, Transfection, Expressing, Control

Figure 2. The effect of DDR2 silencing on dendritic extensions of fibroblasts. (A) Collagen or fibronectin (FN) matrices containing mock and DDR2 siRNA- transfected fibroblasts were polymerized for 1 h with 2x104 cells/matrix. Following polymerization, samples were incubated for 4 h in DMEM containing 50 ng/ml PDGF or 10 µM LPA, as indicated. At the end of the incubations, samples were fixed and stained for actin. Selected images captured from collagen matrices are presented. Scale bar, 50 µm. (B) This is the same as in (A), except that samples were subjected to morphometric analysis. Cells were categorized as having >5 projected dendrites in the cell body as ‘+’ dendrite as shown in the representative micrographs. A total of 30-50 transfected cells were counted for each condition in ~10 fields. Results are given as percentages of cells in each category relative to the total number of cells counted.

Journal: International journal of molecular medicine

Article Title: Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices.

doi: 10.3892/ijmm.2013.1320

Figure Lengend Snippet: Figure 2. The effect of DDR2 silencing on dendritic extensions of fibroblasts. (A) Collagen or fibronectin (FN) matrices containing mock and DDR2 siRNA- transfected fibroblasts were polymerized for 1 h with 2x104 cells/matrix. Following polymerization, samples were incubated for 4 h in DMEM containing 50 ng/ml PDGF or 10 µM LPA, as indicated. At the end of the incubations, samples were fixed and stained for actin. Selected images captured from collagen matrices are presented. Scale bar, 50 µm. (B) This is the same as in (A), except that samples were subjected to morphometric analysis. Cells were categorized as having >5 projected dendrites in the cell body as ‘+’ dendrite as shown in the representative micrographs. A total of 30-50 transfected cells were counted for each condition in ~10 fields. Results are given as percentages of cells in each category relative to the total number of cells counted.

Article Snippet: Primary antibodies were: goat anti-human DDR2 (polyclonal) antibody from R&D Systems (Minneapolis, MN, USA) and Type I rat tail collagen (10.6 mg/ml) purchased from BD Biosciences (Bedford, MA, USA).

Techniques: Transfection, Incubation, Staining

Figure 3. The effect of DDR2 silencing on the adhesion of fibroblasts to the 3D collagen matrix. (A) Mock and DDR2-silenced cells were attached for 30 min to collagen-coated coverslips or matrices, washed and then incubated with medium containing 10 mM EDTA for 40 min. At the end of the incubations, the samples were fixed and stained for actin. Scale bar, 100 µm. (B) An enlarged view of a single cell form elsewhere in (A). DDR2 silencing caused the inhibition of small protrusions induced by EDTA around the membrane, resulting in a weak interaction of fibroblasts to the 3D collagen matrices. Scale bar, 50 µm.

Journal: International journal of molecular medicine

Article Title: Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices.

doi: 10.3892/ijmm.2013.1320

Figure Lengend Snippet: Figure 3. The effect of DDR2 silencing on the adhesion of fibroblasts to the 3D collagen matrix. (A) Mock and DDR2-silenced cells were attached for 30 min to collagen-coated coverslips or matrices, washed and then incubated with medium containing 10 mM EDTA for 40 min. At the end of the incubations, the samples were fixed and stained for actin. Scale bar, 100 µm. (B) An enlarged view of a single cell form elsewhere in (A). DDR2 silencing caused the inhibition of small protrusions induced by EDTA around the membrane, resulting in a weak interaction of fibroblasts to the 3D collagen matrices. Scale bar, 50 µm.

Article Snippet: Primary antibodies were: goat anti-human DDR2 (polyclonal) antibody from R&D Systems (Minneapolis, MN, USA) and Type I rat tail collagen (10.6 mg/ml) purchased from BD Biosciences (Bedford, MA, USA).

Techniques: Incubation, Staining, Inhibition, Membrane

Figure 4. The effect of DDR2 silencing on fibroblast migration in a 3D environment. (A) Floating collagen matrices were prepared containing fibroblasts previously transfected (mock or DDR2 siRNA) as indicated. Samples were incubated for 6 h in DMEM with 5 mg/ml fatty acid-free BSA and 50 ng/ml PDGF or 10 µM LPA added as shown. At the end of the incubation period, samples were fixed and the extent of the matrix contraction was measured. Results shown are averages (means ± SD) from three separate experiments, each carried out in duplicate. (B) Nested collagen matrices were prepared with precontracted floating matrices shown in (A), and incubated for 24 h in a medium containing PDGF. At the end of the incubation time, migrating cells were visualized by staining for actin (green) and propidium iodide (red). Scale bar, 100 µm. (C) Quantification of the cell migration shown in (B). Cell migration index values shown are the averages (means ± SD) of duplicate samples from three separate experiments. Compared to mock-transfected cells, DDR2-silenced fibroblasts showed decreased migration in the PDGF conditions.

Journal: International journal of molecular medicine

Article Title: Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices.

doi: 10.3892/ijmm.2013.1320

Figure Lengend Snippet: Figure 4. The effect of DDR2 silencing on fibroblast migration in a 3D environment. (A) Floating collagen matrices were prepared containing fibroblasts previously transfected (mock or DDR2 siRNA) as indicated. Samples were incubated for 6 h in DMEM with 5 mg/ml fatty acid-free BSA and 50 ng/ml PDGF or 10 µM LPA added as shown. At the end of the incubation period, samples were fixed and the extent of the matrix contraction was measured. Results shown are averages (means ± SD) from three separate experiments, each carried out in duplicate. (B) Nested collagen matrices were prepared with precontracted floating matrices shown in (A), and incubated for 24 h in a medium containing PDGF. At the end of the incubation time, migrating cells were visualized by staining for actin (green) and propidium iodide (red). Scale bar, 100 µm. (C) Quantification of the cell migration shown in (B). Cell migration index values shown are the averages (means ± SD) of duplicate samples from three separate experiments. Compared to mock-transfected cells, DDR2-silenced fibroblasts showed decreased migration in the PDGF conditions.

Article Snippet: Primary antibodies were: goat anti-human DDR2 (polyclonal) antibody from R&D Systems (Minneapolis, MN, USA) and Type I rat tail collagen (10.6 mg/ml) purchased from BD Biosciences (Bedford, MA, USA).

Techniques: Migration, Transfection, Incubation, Staining

(A) CBF assessed by LSCI in WT, APP/PS1, and astrocyte specific Ddr2 overexpressing APP/PS1 mice. Left: Representative pseudocolor perfusion maps. Right: Quantification of relative perfusion units (Mean ± SEM; ** p < 0.01, one-way ANOVA). (B) Correlation between CBF (from A) and cortical Ddr2 mRNA levels (qPCR) across individual mice (Pearson r = −0.6081, p < 0.01). (C) In vivo (top) and ex vivo (bottom) whole brain fluorescence imaging after intravenous injection of the DDR2 targeting probe 1A12-mCherry. (D) Validation of 1A12-mCherry brain delivery and target specificity: Ex vivo brain sections for intrinsic mCherry fluorescence (red), anti-His tag immunofluorescence staining (green), and anti-DDR2 antibody HL2 staining (purple), the areas outlined by white squares are magnified in the adjacent panels. Scale bar: 30 μm for original images and 10 μm for enlarged images. (E) Schematic of the sequential probe injection protocol for vascular perfusion assessment: 1A12-mCherry followed 40 min later by Dextran-FITC (70 kDa). (F) Whole brain fluorescence imaging of vascular perfusion with Dextran-FITC (70 kDa). (G) Two photon microscopy of cortical vasculature. Representative images show mCherry signal (red) and dextran-FITC vasculature (green) in WT, APP/PS1, and APP/PS1-DDR2 mice, scale bars: 50 μm. (H) Representative two-photon microscopy images of vascular leakage after injection of dextran-FITC (4 kDa, green) and dextran-RB (70 kDa, red), scale bars: 50 μm. (I) Ventricular morphology analyzed by MRI based volumetric reconstruction. Left: Representative images of lateral ventricles from each group. Right: Quantification of lateral ventricular volume (Mean ± SEM; * p < 0.05, ** p < 0.01, one-way ANOVA). (J) CSF flow assessed by cisterna magna injection of high molecular weight dextran (70 kDa, green). Fluorescence stereo microscope images displaying the spatial distribution of the glymphatic system (green) in the brains ( top row ), and corresponding whole brain fluorescence imaging system scans of the same brains( bottom row ), scale bars: 2 mm.

Journal: medRxiv

Article Title: A brain-persistent DDR2-degrading antibody reverses Alzheimer’s pathologies by restoring brain fluid dynamics and metabolic clearance

doi: 10.64898/2026.03.17.26348575

Figure Lengend Snippet: (A) CBF assessed by LSCI in WT, APP/PS1, and astrocyte specific Ddr2 overexpressing APP/PS1 mice. Left: Representative pseudocolor perfusion maps. Right: Quantification of relative perfusion units (Mean ± SEM; ** p < 0.01, one-way ANOVA). (B) Correlation between CBF (from A) and cortical Ddr2 mRNA levels (qPCR) across individual mice (Pearson r = −0.6081, p < 0.01). (C) In vivo (top) and ex vivo (bottom) whole brain fluorescence imaging after intravenous injection of the DDR2 targeting probe 1A12-mCherry. (D) Validation of 1A12-mCherry brain delivery and target specificity: Ex vivo brain sections for intrinsic mCherry fluorescence (red), anti-His tag immunofluorescence staining (green), and anti-DDR2 antibody HL2 staining (purple), the areas outlined by white squares are magnified in the adjacent panels. Scale bar: 30 μm for original images and 10 μm for enlarged images. (E) Schematic of the sequential probe injection protocol for vascular perfusion assessment: 1A12-mCherry followed 40 min later by Dextran-FITC (70 kDa). (F) Whole brain fluorescence imaging of vascular perfusion with Dextran-FITC (70 kDa). (G) Two photon microscopy of cortical vasculature. Representative images show mCherry signal (red) and dextran-FITC vasculature (green) in WT, APP/PS1, and APP/PS1-DDR2 mice, scale bars: 50 μm. (H) Representative two-photon microscopy images of vascular leakage after injection of dextran-FITC (4 kDa, green) and dextran-RB (70 kDa, red), scale bars: 50 μm. (I) Ventricular morphology analyzed by MRI based volumetric reconstruction. Left: Representative images of lateral ventricles from each group. Right: Quantification of lateral ventricular volume (Mean ± SEM; * p < 0.05, ** p < 0.01, one-way ANOVA). (J) CSF flow assessed by cisterna magna injection of high molecular weight dextran (70 kDa, green). Fluorescence stereo microscope images displaying the spatial distribution of the glymphatic system (green) in the brains ( top row ), and corresponding whole brain fluorescence imaging system scans of the same brains( bottom row ), scale bars: 2 mm.

Article Snippet: The primary antibodies used in this study were as follows: anti-DDR2 (1:1000; Servicebio, GB112568), anti-DDR2 (1:1000, R&D, AF2538), anti-BACE1 (1:50; Cell Signaling Technology, no. 5606), anti-Collagen IV (1:1000; abcam, ab6586), anti-PDGFRβ (1:1000; Cell Signaling Technology, no. 3169), anti-Occludin (1:1000; Cell Signaling Technology, no. 91131), anti-ZO1 (1:1000; abcam, ab276131), anti-β-actin (1:1000; Yeasen, 30102ES60).

Techniques: In Vivo, Ex Vivo, Fluorescence, Imaging, Injection, Biomarker Discovery, Immunofluorescence, Staining, Microscopy, High Molecular Weight